Insuficiencia hepática aguda por adenovirus tratada con inmunoglobulina intravenosa
Revista Alergia México · 2024
DOI: 10.29262/8ebk3v48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Alergia México, 2024. Verfasst von Melissa Zavala Rodríguez und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Acute liver failure in pediatric age is a serious multisystem disease, characterized by a failure of the synthesis and detoxification function of the liver. Among the etiologies, viral infection should be investigated. Treatment is supportive and some cases require liver transplantation. Case report: A 2-year-old girl was admitted for acute liver failure. The PCR viral panel was positive for Adenovirus 41 and IgG antibodies to SARS-CoV-2 were also found. Supportive treatment was started without improvement, so intravenous immunoglobulin was administered, with resolution of the liver failure.
Conclusion
Immunoglobulin has immunomodulatory mechanisms in children with severe acute hepatitis of infectious etiology, so in some cases, its administration can be considered as adjuvant therapy. Keywords: Acute liver failure, Hepatitis, Adenovirus, Immunoglobulin.
Zitieren
APA
Rodríguez, M. Z., Triana, M. A. M., Morales, M. D. R. H., & Vélez, R. P. (2024). Insuficiencia hepática aguda por adenovirus tratada con inmunoglobulina intravenosa. Revista Alergia México. https://doi.org/10.29262/8ebk3v48
Vancouver
Rodríguez MZ, Triana MAM, Morales MDRH, Vélez RP. Insuficiencia hepática aguda por adenovirus tratada con inmunoglobulina intravenosa. Revista Alergia México. 2024. doi:10.29262/8ebk3v48
BibTeX
@article{Rodrguez2024,
author = {Rodríguez, Melissa Zavala and Triana, Marco Antonio Martínez and Morales, María del Rocío Hernández and Vélez, Rubén Peña},
title = {Insuficiencia hepática aguda por adenovirus tratada con inmunoglobulina intravenosa},
journal = {Revista Alergia México},
year = {2024},
doi = {10.29262/8ebk3v48}
}
EUVIMED